Skip to main content
NIH funding notice PAR-21-341

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Closed on October 8, 2024.

Posted
October 12, 2021
Close date
October 8, 2024
Activity codes
R21
Institutes taking part
NCI

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

  1. Reissues: PAR-19-277 Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional)
  2. 2 steps back: PA-16-175 Exploratory Grants in Cancer Epidemiology and Genomics Research (R21)

Replaced by PA-25-253.

Who won it before

41 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $11,848,459 in first-year total cost, median $245,120.

Most frequent study sections

  1. Cancer, Heart, and Sleep Epidemiology B Study Section[CHSB]6
  2. Cancer, Heart, and Sleep Epidemiology A Study Section[CHSA]5
  3. Biobehavioral Medicine and Health Outcomes Study Section[BMHO]3
  4. Cancer and Hematologic Disorders Study Section[CHD]3
  5. Chemo/Dietary Prevention Study Section[CDP]3

Most frequent institutions

  1. ARIZONA STATE UNIVERSITY-TEMPE CAMPUS2
  2. CEDARS-SINAI MEDICAL CENTER2
  3. HARVARD SCHOOL OF PUBLIC HEALTH2
  4. MASSACHUSETTS GENERAL HOSPITAL2
  5. MAYO CLINIC ROCHESTER2
Competing awards under PAR-21-341 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Using targeted and non-targeted approaches to examine per- and polyfluoroalkyl substances (PFAS) exposure and glioma risk in young children1R21CA293549-01A1MA, XIAOMEIPOLLITT, KRYSTALYALE UNIVERSITY, CT$431,377ZRG1
2025Recalibrating the Lung Cancer Policy Model to Address Lung Cancer Risk and Lung Cancer Screening Practices in Real-World Populations1R21CA301039-01YANG, CHI-FUMASSACHUSETTS GENERAL HOSPITAL, MA$429,399ODHS
2025Generalized and Cancer-Related Episodic Future Thinking for Smoking Cessation: Proof-of-Concept and Feasibility Testing1R21CA294049-01A1STEIN, JEFFREY SCOTTVIRGINIA POLYTECHNIC INST AND ST UNIV, VA$395,248IPTA
2025Epigenetics, accelerated aging, and cardiovascular health during breast cancer treatment1R21CA300956-01VASBINDER, ALEXI LUNIVERSITY OF WASHINGTON, WA$279,411CCHS
2025BReaTHS: Breast cancer Radiation Training for improved Heart Safety1R21CA300943-01SALWEI, MEGAN ELIZABETHVANDERBILT UNIVERSITY MEDICAL CENTER, TN$246,124ZRG1
2025Developing AI-measures of Pedestrian Environment Features for Physical Activity and Cancer Prevention in Rural Communities1R21CA293976-01A1ADAMS, MARC AWENDE, MARILYN ELIZABETHARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ$231,710CIHB
2025Cancer Care Companion: An Electronic Health Record Tool to Improve Information Exchange and Self-Management in Pediatric Cancer1R21CA290223-01A1SISK, BRYAN ANTHONYWASHINGTON UNIVERSITY, MO$227,941ICSC
2024A Blended e-Health Intervention for Fear of Progression in Advanced GYN Cancer1R21CA293326-01REB, ANNEBECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA$489,500CMGC
2024Assessment of consumer response to smokeless tobacco modified risk marketing orders1R21CA289541-01O'CONNOR, RICHARD JWACKOWSKI, OLIVIAROSWELL PARK CANCER INSTITUTE CORP, NY$443,509LHB
2024Epidemiologic study of microplastic pollution in bronchoalveolar lavage fluid and its association with lung cancer1R21CA293440-01EGAN, KATHLEEN M.H. LEE MOFFITT CANCER CTR & RES INST, FL$425,772CHD
2024Role of the inflammatory dietary pattern in gut and colon tissue microbiomes and impact on survival outcomes among colorectal cancer patients1R21CA294050-01TABUNG, FRED KINYUYOHIO STATE UNIVERSITY, OH$405,316CHD
2024The Role of Early Life Exposure to Antibiotics on Risk of Early Onset Colorectal Cancer1R21CA281729-01A1PENA, MARIA MARJORETTEUNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC$372,142CPSS
2024Identifying and Addressing Barriers in the Cervical Cancer Treatment Cascade among Women with HIV in South Africa1R21CA279942-01A1PSAROS, CHRISTINASTANTON, AMELIA M.BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA$368,070PPAH
2024Sexual Health and Rehabilitation (SHARE): An Online Educational Intervention for Young Adult Female Cancer Survivors1R21CA279278-01A1BOBER, SHARON L.DANA-FARBER CANCER INST, MA$255,280BMHO
2024Caregiver Education with Interactive Neurodevelopmental Games to Improve Cognitive and Social-Emotional Outcomes in Infants Undergoing Treatment for Medulloblastoma1R21CA280187-01A1CONKLIN, HEATHER MST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN$251,912PDRP
2024Clonal growth and prediction of monoclonal B-cell lymphocytosis1R21CA282702-01A1GRIFFIN, ROSALIESEKAR, ASWINMAYO CLINIC ROCHESTER, MN$245,120CHD
2024Understanding patient-surgeon interactions to support deimplementation of preference-sensitive low value care1R21CA283601-01A1NEUMAN, HEATHER BUNIVERSITY OF WISCONSIN-MADISON, WI$194,714SIHH
2024Innovating CBT-I for Cancer Survivors: An Optimization Trial1R21CA279248-01A1HALL, DANIEL LEEMASSACHUSETTS GENERAL HOSPITAL, MA$187,935BMHO
2023Mates in Motion: Feasibility and Acceptability of a Couple-Based Physical Activity Intervention1R21CA275085-01A1LANGER, SHELBYARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ$419,253LCBH
2023The Feasibility and Acceptability of Resistance Training and Creatine Supplementation to Promote Physical Function in Sarcopenic Colorectal Cancer Survivors1R21CA281951-01FAIRMAN, CIARANUNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC$202,696BMHO
2022Leveraging Medicare Linkages to Identify New Associations: Prescription Drugs and Digestive Cancer Risk1R21CA263489-01A1 · under PAR-19-277BYKOV, KATSIARYNADU, MENGMENGKANTOR, ELIZABETH DAVIDSLOAN-KETTERING INST CAN RESEARCH, NY$488,048CHSB
2022Breast cancer neoadjuvant endocrine therapy during the Covid-19 pandemic: Opportunity for a new treatment paradigm?1R21CA270625-01 · under PAR-19-277NYANTE, SARAH JANEUNIV OF NORTH CAROLINA CHAPEL HILL, NC$181,741CBSS
2021Inflammatory oxylipins and aromatase inhibitor toxicity in breast cancer1R21CA251343-01A1 · under PAR-19-277HENRY, NORAH LYNNUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$427,833CHSB
2021Informing Cancer Epidemiology Through the Identification of Differentiating Chemical Constituents of Cigarillo Smoke1R21CA263809-01 · under PAR-19-277KLUPINSKI, THEODORE P.BATTELLE CENTERS/PUB HLTH RES & EVALUATN, OH$409,936SIEE
2020Metabolomic and miRNA profiling of vitreous humor in uveal melanoma1R21CA241840-01A1 · under PAR-19-277DEMIRCI, F. YESIMUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$415,342CBSS
2020Modeling multiple environmental exposures and childhood leukemia risk1R21CA238370-01A1 · under PA-16-175WHEELER, DAVID CHARLESVIRGINIA COMMONWEALTH UNIVERSITY, VA$226,490CHSB
2019Circulating Antibodies to Oral Microbiota and Colon Cancer Risk1R21CA234436-01 · under PA-16-175MICHAUD, DOMINIQUE S.TUFTS UNIVERSITY BOSTON, MA$250,540CHSB
2019Computational Identification of new candidate drugs for lung cancer treatment1R21CA227996-01A1 · under PA-16-175CHENG, CHAOONEGA, TRACYBAYLOR COLLEGE OF MEDICINE, TX$222,863BCHI
2019Profiling DNA adducts in formalin fixed paraffin embedded human colorectal tissue1R21CA235094-01A1 · under PA-16-175TURESKY, ROBERT J.UNIVERSITY OF MINNESOTA, MN$212,715CPSS
2019Genetic Epidemiology of Breast Cancer Disparities in Women of African Ancestry1UH2CA227608-01A1 · under PA-16-175OCHS-BALCOM, HEATHER MSTATE UNIVERSITY OF NEW YORK AT BUFFALO, NY$192,184CHSB
2019Improving confounder control in EHR-based studies of cancer epidemiology1R21CA227613-01A1 · under PA-16-175HUBBARD, REBECCAUNIVERSITY OF PENNSYLVANIA, PA$186,664CHSA
2019Development of an automated method to capture bladder cancer recurrence and progression for epidemiologic research1R21CA227606-01A1 · under PA-16-175DANFORTH, KIM NKAWATKAR, ANIKET AKAISER FOUNDATION RESEARCH INSTITUTE, CA$172,270CHSA
2018Integrating diet, lifestyle and tumor tissue molecular subtyping to study the role of adolescent calcium intake on the risk of early onset colorectal neoplasia1R21CA230873-01 · under PA-16-175OGINO, SHUJIWU, KANAHARVARD SCHOOL OF PUBLIC HEALTH, MA$246,987CDP
2018Integrating diet and tissue whole exome sequencing data to study processed meat and colorectal cancer1R21CA222940-01 · under PA-16-175NISHIHARA, REIKOWU, KANAHARVARD SCHOOL OF PUBLIC HEALTH, MA$243,471CDP
2018Estimation and association analysis of biomarkers for tumor immune microenvironment1R21CA224026-01 · under PA-16-175SUN, WEIFRED HUTCHINSON CANCER RESEARCH CENTER, WA$229,680BMRD
2018T cell responses shared among triple negative breast cancer patients1R21CA230487-01 · under PA-16-175SLANSKY, JILL EUNIVERSITY OF COLORADO DENVER, CO$209,895CII
2018Epidemiology and Genomics of Ovarian Clear Cell Carcinoma1R21CA222867-01A1 · under PA-16-175GOODE, ELLEN L.MAYO CLINIC ROCHESTER, MN$207,495CHSA
2018Predicting the diagnosis of pancreatic cancer by leveraging big data1R21CA220073-01A1 · under PA-16-175JEON, CHRISTIE YOUNGHAECEDARS-SINAI MEDICAL CENTER, CA$203,197CHSB
2018Improving Breast Cancer Risk Prediction with Composite Measures of Obesity and Body Fat Distribution1R21CA220080-01A1 · under PA-16-175SHVETSOV, YURII BUNIVERSITY OF HAWAII AT MANOA, HI$200,970CHSA
2018Understanding sex differences in colon cancer metabolism1R21CA223686-01A1 · under PA-16-175JOHNSON, CAROLINE HELENKHAN, SAJID AYALE UNIVERSITY, CT$182,156CDP
2017The Role of Splice Quantitative Traits in Ovarian Cancer Pathogenesis1R21CA220078-01 · under PA-16-175LAWRENSON, KATEPASANIUC, BOGDANCEDARS-SINAI MEDICAL CENTER, CA$235,553CHSA

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-21-341: Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) | ScienceDex | ConductScience